TANGO THERAPEUTICS, INC. (a Delaware corporation) 21,023,337 Shares of Common Stock And Pre-Funded Warrants to Purchase 3,226,458 of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • October 24th, 2025 • Tango Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 24th, 2025 Company Industry JurisdictionTango Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement with Leerink Partners LLC (“Leerink Partners”) and each of the other Underwriters named in Schedule A hereto (collectively, the “Underwriters,” which term shall also include any underwriter substituted as hereinafter provided in Section 10 hereof), for which Leerink Partners is acting as representative (in such capacity, the “Representative”), with respect to the sale by the Company and the purchase by the Underwriters, acting severally and not jointly, of (i) an aggregate of 21,023,337 shares (the “Shares”) of its common stock, par value $0.001 per share (the “Common Stock”), and (ii) pre-funded warrants of the Company to purchase up to an aggregate of 3,226,458 shares of common stock (the “Pre-Funded Warrants”) as set forth in Schedule A hereto. The Shares and Pre-Funded Warrants are hereinafter called the “Securities”. As used herein, “Warrant Shares” means the shares of common stock issuable up
TAMBORAN RESOURCES CORPORATION (a Delaware corporation) 2,324,445 Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • October 24th, 2025 • Tamboran Resources Corp • Crude petroleum & natural gas • New York
Contract Type FiledOctober 24th, 2025 Company Industry Jurisdiction